Petermac Logo

Clinical trials

Image: Peter Mac clinical trial nurses monitoring a patient on a trial

Clinical trials are integral to Peter Mac’s unique standing as a research-oriented public cancer hospital and the foundation upon which clinical medicine is practised.

There are over 200 clinical trials active in cancer at Peter Mac at any one time. These trials are either investigator-driven, led by clinician-researchers from Peter Mac, or conducted in collaboration with the pharmaceutical industry. Trials commonly involve new cancer medicines, and also examine new approaches to surgery, radiation therapy, supportive care, pain control or ways of imaging and staging tumours.

Peter Mac’s multi-disciplinary clinical trials teams use cutting-edge approaches, including sophisticated cancer imaging technologies to evaluate cellular responses, all in close proximity to research laboratories and clinical areas, encouraging the dynamic exchange of ideas for the benefit of all people with cancer.

As part of a public cancer hospital, which treats around 30,000 cancer patients each year, Peter Mac researchers have direct access to a large number of tumour biopsies, including of rare cancer types, which can be taken at baseline and critical stages of disease progression.

Central to the success of Peter Mac’s clinical trials are many research leaders of world renown. Innovators in their fields, many of these researchers also treat people with cancer; this day-to-day interaction between the laboratory and the clinic energises Peter Mac’s  researchers to challenge conventional thinking in the pursuit of safer, gentler and more effective cancer treatments.

Back to top >


Research directions

In recent years, clinical trials in which Peter Mac has provided intellectual leadership, was the lead site for, or a major contributor to, and which have led to many world-first research achievements, include:

Many trials at Peter Mac are performed through national and international collaborative groups, such as the Australasian Leukaemia and Lymphoma Group (ALLG), Australia and New Zealand Breast Cancer Trials Group (ANZBCTG), Australia New Zealand Gynaecological Oncology Group (ANZGOG), Australian and New Zealand Urogenital and Prostate (ANZUP) Cancer Trials Group, Australian Gastrointestinal Tumour Trials Group (AGITG), Cancer Council Victoria’s Clinical Network (Neuro-oncology Group), Children’s Oncology Group, European Organisation for Research and Treatment of Cancer (EORTC), and the Trans-Tasman Radiation Oncology Group (TROG).

Peter Mac supports and recommends all patients consider participation in appropriate, ethically approved clinical trials.

Back to top >


Joining a Peter Mac clinical trial

It is not possible to join a Peter Mac clinical trial without referral from your treating oncologist. View how you can participate in research studies or how to refer a patient to a clinical trial at Peter Mac.

Back to top >



Related experts

Melbourne Digital Agency - Icon